<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Objective </plain></SENT>
<SENT sid="1" pm="."><plain>Drugs can induce almost the entire spectrum of <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e>, affecting white cells, red cells, platelets, and the coagulation system </plain></SENT>
<SENT sid="2" pm="."><plain>This paper aims to emphasize the broad range of drug-induced hematological syndromes and to highlight some of the newer drugs and syndromes </plain></SENT>
<SENT sid="3" pm="."><plain>Methods </plain></SENT>
<SENT sid="4" pm="."><plain>Medline literature on drug-induced hematologic syndromes was reviewed </plain></SENT>
<SENT sid="5" pm="."><plain>Most reports and reviews focus on individual drugs or cytopenias </plain></SENT>
<SENT sid="6" pm="."><plain>Results </plain></SENT>
<SENT sid="7" pm="."><plain>Drug-induced syndromes include <z:hpo ids='HP_0001878'>hemolytic anemias</z:hpo>, <z:hpo ids='HP_0012119'>methemoglobinemia</z:hpo>, red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo>, <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo>, <z:hpo ids='HP_0001901'>polycythemia</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0001974'>leukocytosis</z:hpo>, <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, <z:hpo ids='HP_0001880'>eosinophilia</z:hpo>, <z:hpo ids='HP_0001973'>immune thrombocytopenia</z:hpo>, microangiopathic syndromes, <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo>, <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">hypoprothrombinemia</z:e>, circulating <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Some of the classic drugs known to cause hematologic abnormalities have been replaced by newer drugs, including biologics, accompanied by their own syndromes and unintended side effects </plain></SENT>
<SENT sid="9" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="10" pm="."><plain>Drugs can induce toxicities spanning many hematologic syndromes, mediated by a variety of mechanisms </plain></SENT>
<SENT sid="11" pm="."><plain>Physicians need to be alert to the potential for iatrogenic drug-induced hematologic complications </plain></SENT>
</text></document>